Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 13/20 | 0.76 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.61 |
| ▸ | CYP11B1 | P15538 | 5/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6120541 | 0.89 | KIF11 (0.69) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL3903111 | 0.87 | KIF11 (0.72) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL3896158 | 0.87 | KIF11 (0.72) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL3899619 | 0.87 | KIF11 (1.00) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL29320009 | 0.85 | KIF11 (0.76) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL13002525 | 0.82 | KIF11 (0.70) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL28295960 | 0.82 | KIF11 (0.56) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL12473617 | 0.81 | KIF11 (0.55) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL13615055 | 0.81 | CYP11B2 (0.56) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL3900837 | 0.81 | KIF11 (0.64) | KIF11CYP11B2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| EP-3478656-B1 | DICARBAZOLE DIPHENYL DERIVATIVES FOR USE IN OPTOPELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-09-08 | — | — | EP | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | KIF11 3544/4885CYP11B2 1090/4885CYP11B1 1343/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | KIF11 3520/4885CYP11B2 1121/4885CYP11B1 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.